Oudard S - Search Results

1

[Collecting duct carcinoma and renal medullary carcinoma in the age of new therapies].

Guillaume Z, Allory Y, Auclin E, Gervais C, Auvray M, Rochand A, Mejean A, Audenet F, Vano YA, Oudard S, Thibault C. Guillaume Z, et al. Among authors: oudard s. Bull Cancer. 2023 Apr;110(4):450-462. doi: 10.1016/j.bulcan.2023.02.015. Epub 2023 Mar 9. Bull Cancer. 2023. PMID: 36906403 Review. French.

2

[Metastatic kidney cancer: new therapeutic approaches].

Negrier S, Mejean A, Oudard S, Escudier B. Negrier S, et al. Among authors: oudard s. Prog Urol. 2002 Sep;12(4):703-8. Prog Urol. 2002. PMID: 12463140 Review. French.

3

Prognostic factors of renal cell carcinoma.

Méjean A, Oudard S, Thiounn N. Méjean A, et al. Among authors: oudard s. J Urol. 2003 Mar;169(3):821-7. doi: 10.1097/01.ju.0000051378.14270.2a. J Urol. 2003. PMID: 12576793 Review.

4

Serum PSA half-life as a predictor of survival for hormone-refractory prostate cancer patients: modelization using a standardized set of response criteria.

Banu E, Banu A, Medioni J, Levy E, Thiounn N, Mejean A, Andrieu JM, Oudard S. Banu E, et al. Among authors: oudard s. Prostate. 2007 Oct 1;67(14):1543-9. doi: 10.1002/pros.20627. Prostate. 2007. PMID: 17705243

5

[New targeted therapies in hormone-refractory prostate cancer].

Oudard S, Banu E, Scotte F, Beuzeboc P, Guyader C, Medioni J. Oudard S, et al. Bull Cancer. 2007 Jul;94(7 Suppl):F62-8. Bull Cancer. 2007. PMID: 17845995 Review. French.

6

Salvage therapy with bevacizumab-sunitinib combination after failure of sunitinib alone for metastatic renal cell carcinoma: a case series.

Medioni J, Banu E, Helley D, Scotte F, Fournier L, Mejean A, Chedid A, Azizi M, Andrieu JM, Oudard S. Medioni J, et al. Among authors: oudard s. Eur Urol. 2009 Jul;56(1):207-11; quiz 211. doi: 10.1016/j.eururo.2009.01.001. Epub 2009 Jan 13. Eur Urol. 2009. PMID: 19157688

7

[Angiogenesis inhibition: review of the activity of sorafenib, sunitinib and bevacizumab].

Barrascout E, Medioni J, Scotte F, Ayllon J, Mejean A, Cuenod CA, Tartour E, Elaidi R, Oudard S. Barrascout E, et al. Among authors: oudard s. Bull Cancer. 2010;97:29-43. doi: 10.1684/bdc.2010.1068. Bull Cancer. 2010. PMID: 20418202 Review. French.

8

Integrating surgery with targeted therapies for renal cell carcinoma: current evidence and ongoing trials.

Bex A, Jonasch E, Kirkali Z, Mejean A, Mulders P, Oudard S, Patard JJ, Powles T, van Poppel H, Wood CG. Bex A, et al. Among authors: oudard s. Eur Urol. 2010 Dec;58(6):819-28. doi: 10.1016/j.eururo.2010.08.029. Epub 2010 Aug 27. Eur Urol. 2010. PMID: 20828919 Review.

9

A decrease of regulatory T cells correlates with overall survival after sunitinib-based antiangiogenic therapy in metastatic renal cancer patients.

Adotevi O, Pere H, Ravel P, Haicheur N, Badoual C, Merillon N, Medioni J, Peyrard S, Roncelin S, Verkarre V, Mejean A, Fridman WH, Oudard S, Tartour E. Adotevi O, et al. Among authors: oudard s. J Immunother. 2010 Nov-Dec;33(9):991-8. doi: 10.1097/CJI.0b013e3181f4c208. J Immunother. 2010. PMID: 20948437 Clinical Trial.

10

[Bellini tumours].

Teghom C, Gachet J, Scotté F, Elaidi R, Oudard S. Teghom C, et al. Among authors: oudard s. Bull Cancer. 2011 Oct;98(10):1230-2. doi: 10.1684/bdc.2011.1462. Bull Cancer. 2011. PMID: 22001860 Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

443 results

Search Page

Filters